2 relations: Care Continuum Alliance, Methylhexanamine.
Care Continuum Alliance
The Care Continuum Alliance (formerly DMAA: The Care Continuum Alliance) is an industry trade group of corporations and individuals that "promotes the role of population health improvement in raising the quality of care, improving health outcomes and reducing preventable health care costs for individuals with chronic conditions and those at risk for developing chronic conditions".
New!!: DMAA and Care Continuum Alliance · See more »
Methylhexanamine
Methylhexanamine (trade names Forthane, Geranamine) or methylhexamine, commonly known as 1,3-dimethylamylamine (1,3-DMAA) or simply dimethylamylamine (DMAA), is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1944 until it was voluntarily withdrawn from the market in 1983.
New!!: DMAA and Methylhexanamine · See more »